+ Watch MNKD
on My Watchlist
A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Big pharma has lost several big blockbuster drugs to expiring exclusivity over the past year and will be looking to aquire potential replacements. Mnkd's drug candidate Afrezza fits perfectly bacause of diabetes broad and dramatically increasing population. Upon positive trial news sometime in the middle of 2013 I expect Big Pharma to come in swiftly.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions